Navigation Links
BioMS Medical Announces 2008 Year End Results
Date:3/17/2009

,921 Amortization of licensing costs 11,755 1,472 1,472 Amortization of property and equipment 517 125 134 Loss on disposal of property and equipment 11 11 - ------------ -------- -------- (118,881) 3,343 (43,681) Net change in non-cash working capital items Goods and services tax recoverable (299) 185 (28) Prepaid and other current assets (2,548) 734 (571) Advanced clinical trial costs (790) 1,186 (1,976) Accounts payable and accrued liabilities 9,151 (601) 933 Deferred revenue 45,605 45,605 - ------------ -------- -------- (67,762) 50,452 (45,323) ------------ -------- -------- Investing activities Purchase of property and equipment (1,045) (323) (109) Net (purchase of) proceeds from short-term investments (2,614) (86) 3,149 Licensing costs (6,467) - - ------------ -------- -------- (10,126) (409) 3,040 ------------ -------- -------- Financing activities Proceeds from issuance of share capital 178,729 91 44,512 Repurchase of share capital (3,552) (1,434) (36) Share issue costs (12,312) - (3,332)
'/>"/>
SOURCE BioMS Medical Corp.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. BioMS Medical warrant extension
2. BioMS Medical to present at BIO CEO and Investor Conference
3. BioMS Medical reports results of exploratory phase II trial of dirucotide in relapsing remitting multiple sclerosis
4. BioMS Medical recognized at Scrip Awards 2008
5. BioMS Medical Announces Third Quarter 2008 Results
6. BioMS Medical to present at Rodman and Renshaw Annual Healthcare Conference
7. BioMS Medicals relapsing-remitting multiple sclerosis trial receives positive review from Data Safety Monitoring Board
8. BioMS Medicals phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board
9. BioMS Medical announces receipt of milestone payment from Eli Lilly and Company
10. BioMS Medical to present at Sachs Associates Biotech in Europe Forum
11. BioMS Medical to present at UBS Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... ... July 06, 2015 , ... Discovery ... diagnostic tests are key drivers of the global molecular diagnostics market. BCC Research ... the introduction of new companion diagnostic tests will increase demand for inexpensive and ...
(Date:7/6/2015)... , July 6, 2015  Viveve Medical, Inc. ("Viveve") (OTCQB: VIVMF), ... Patricia Scheller , Viveve,s Chief Executive Officer, and Scott ... VirtualInvestorConferences.com on July 9, 2015. , , , ... , , , TIME:     , , , ... , , , http://tinyurl.com/viveve   , ...
(Date:7/6/2015)... July 6, 2015 ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") ... agreement with Novella Clinical (Novella), to conduct ... with newly diagnosed glioblastoma. Novella is a full-service, global ... small to mid-sized oncology companies. The ICT-107 phase 3 ... US, Europe and ...
(Date:7/3/2015)... ... July 03, 2015 , ... ... in applications such as animal waste reduction, bioremediation, wastewater treatment, aquaculture and ... settings, announced today that it will be showcasing, ManureMagicâ„¢, its industry-leading product ...
Breaking Biology Technology:Demand for Personalized Medicine, Innovative Molecular Diagnostic Tests Spurring Big Growth, According to BCC Research 2Demand for Personalized Medicine, Innovative Molecular Diagnostic Tests Spurring Big Growth, According to BCC Research 3Viveve to Webcast Live at VirtualInvestorConferences.com 2Viveve to Webcast Live at VirtualInvestorConferences.com 3ImmunoCellular Therapeutics Establishes Agreement with Novella Clinical to Conduct ICT-107 Phase 3 Registration Trial in Glioblastoma 2DryLet to Highlight Benefits of Patented ManureMagicâ„¢ at North American Manure Expo in Chambersburg, PA July 14-15, 2015 2
... Midwest at places like the Maytag plant in Galesburg, Ill., which ... many experts giving opinions about why these jobs are disappearing. ... cheaper wages and most stop there with their strategic analysis. That ... so focused on the bottom line. Its a safe bet for ...
... and technology industries are a major strength of the ... economic health of the state. These industries reflect ... healthcare technologies and devices. Concentration of this knowledge ... products and services in the device and technology arena. ...
... market research on an ongoing basis is the most ... for many companies, the benefits of conducting marketing research ... to be at odds: , ,Marketing research can ... costly. , ,The traditional solution to this quagmire is ...
Cached Biology Technology:Spend Money to Make Money and Dump Obsolete Tech Strategies 2Spend Money to Make Money and Dump Obsolete Tech Strategies 3Spend Money to Make Money and Dump Obsolete Tech Strategies 4Talking Bout My Generation: The Evolution of Online Marketing Research 2Talking Bout My Generation: The Evolution of Online Marketing Research 3
(Date:6/16/2015)... /CNW Telbec/ - handyem Inc. and FlowMetric Diagnostics ... of handyem,s HPC-150 portable flow cytometer within FlowMetric ... unprecedented model of mobile laboratory platform is presented ... Pennsylvania Convention Center, ... to 18 th 2015.  By virtue of ...
(Date:6/15/2015)... , June 15, 2015 A ... from Telstra reveals the majority of US consumers using mobile ... via biometrics, such as fingerprint and voiceprint, instead of having ... According to Telstra,s " Mobile Identity   -   ... report, with smartphones now the primary channel used by ...
(Date:6/9/2015)...   MedNet Solutions , an innovative SaaS-based eClinical ... research, will be providing demonstrations of its ... Drug Information Association (DIA) Annual Meeting in ... will include previews of many exciting new enhancements that ... iMedNet 2015 Feature 1 Release. ...
Breaking Biology News(10 mins):handyem and FlowMetric Diagnostics announce their partnership in the development of Flow Cytometry- Based Solutions in diagnostic capabilities 2handyem and FlowMetric Diagnostics announce their partnership in the development of Flow Cytometry- Based Solutions in diagnostic capabilities 3One in Four US Consumers Would Share Their DNA With Their Bank to Secure Financial and Personal Information, Telstra Report Finds 2One in Four US Consumers Would Share Their DNA With Their Bank to Secure Financial and Personal Information, Telstra Report Finds 3One in Four US Consumers Would Share Their DNA With Their Bank to Secure Financial and Personal Information, Telstra Report Finds 4MedNet To Provide Sneak Peeks Of Its iMedNet "2015 Feature 1 Release" At The DIA Annual Meeting 2MedNet To Provide Sneak Peeks Of Its iMedNet "2015 Feature 1 Release" At The DIA Annual Meeting 3
... Kentucky plant pathologists recently discovered a metabolite that plays a ... humans and one-celled microorganisms to fend off a wide range ... systemic immunity. This mode of resistance has been known for ... that resistance have remained a mystery. The findings of ...
... How exactly bacterial pathogens cause diseases in plants ... to solve this problem. Now Wenbo Ma ... California, Riverside, has performed research on the soybean plant ... understanding of plant-pathogen interactions, a rapidly developing area among ...
... by researchers at the San Diego Supercomputer Center at ... to study evolutionary relationships among large populations of living ... to understand how to operate large, complex computer systems. ... (Cyberinfrastructure for Phylogenetic RESearch) Gateway, is an ...
Cached Biology News:Kentucky researchers find a key to plant disease resistance 2How do plants fight disease? 2How do plants fight disease? 3SDSC's CIPRES Gateway provides window to the past -- and fast 2SDSC's CIPRES Gateway provides window to the past -- and fast 3
IMAGEQUANT 100 IQTL, 1 EA. Category: ImageQuant CCD Imagers....
ImageQuant 100 UV, 1 EA. Category: ImageQuant CCD Imagers....
The FlowTACS Apoptosis Detection Kit is designed specifically for in situdetection of apoptotic...
...
Biology Products: